Global Public Affairs Head, Rare Neuromuscular and Sickle Cell Disease - Cambridge

Advanced Practice Provider:   Sickle Cell Disease and Hemoglobinopathies · The Section of Hematology and Medical Oncology, Boston University Aram V. Chobanian and Edward Avedisian School of Medicine and Boston Medical Center, · seeks an Advanced Practice Provider to support its e ...

· Scismic is supporting the growth of a Cambridge, MA biotech startup that is pioneering mRNA-modulating therapies to cure a broad range of genetic diseases. The company is exploring the use of its novel platforms in neurological disorders, heart disease, and muscular dystrophie ...

About BlueRock Therapeutics · BlueRock Therapeutics, a wholly owned and independently operated subsidiary of Bayer AG, is a clinical-stage engineered cell therapy company pioneering a new generation of cellular medicines. Powered by our proprietary · CELL+GENE platform · , we dir ...

The Director, Program Management – DA02 will provide strategic and operational leadership for the DA02 neurology program as it advances toward IND submission and first in human clinical studies. · ...

Who is BlueRock? · BlueRock Therapeutics LP is a clinical stage cell therapy harnessing the power of cell therapy to create a pipeline of new medicines for people suffering from neurological and ophthalmic diseases. Two of our novel investigational cell therapies, bemdaneprocel ...

· About BlueRock Therapeutics  · CELL+GENE platform, we direct cellular differentiation and apply precise genetic engineering to create transformative therapies for patients with serious neurological and ophthalmological diseases.  · Founded in 2016, BlueRock sits at the interse ...

The Procurement Buyer will play a key role in supporting the procurement function within a dynamic biotech/pharmaceutical environment. · Review and process purchase requisitions for goods and services. · ...

The Director, Program Management – DA02 will provide strategic and operational leadership for the DA02 neurology program as it advances toward IND submission and first in human clinical studies. · ...

Who is BlueRock? · BlueRock Therapeutics LP is a clinical stage cell therapy harnessing the power of cell therapy to create a pipeline of new medicines for people suffering from neurological and ophthalmic diseases. Two of our novel investigational cell therapies, bemdaneprocel ( ...

· Who is BlueRock? · BlueRock Therapeutics LP is a clinical stage cell therapy harnessing the power of cell therapy to create a pipeline of new medicines for people suffering from neurological and ophthalmic diseases. Two of our novel investigational cell therapies, bemdaneproce ...

Scholar Rock is seeking an outstanding individual to play an important role in the discovery and development of novel biotherapeutics for neuromuscular disorders. · The successful candidate will join the Discovery Biology group to run cell-based assays and perform ex vivo tissue ...

We are seeking a highly motivated scientist to conduct preclinical drug discovery research for retinal diseases including age-related macular degeneration and glaucoma. · Design execute and document translational research studies to validate therapeutic targets and discover precl ...

The Procurement Buyer will play a key role in supporting the procurement function within a dynamic biotech/pharmaceutical environment. · Review and process purchase requisitions for goods and services. · Source suppliers and obtain competitive proposals to ensure cost-effective p ...

· Who is BlueRock? · BlueRock Therapeutics LP is a clinical stage cell therapy harnessing the power of cell therapy to create a pipeline of new medicines for people suffering from neurological and ophthalmic diseases. Two of our novel investigational cell therapies, bemdaneproce ...

Who is BlueRock? · BlueRock Therapeutics LP is a clinical stage cell therapy harnessing the power of cell therapy to create a pipeline of new medicines for people suffering from neurological and ophthalmic diseases. Two of our novel investigational cell therapies, bemdaneprocel ( ...

· We engineer stem cell transplants that shield healthy cells from targeted therapies · Targeted therapies work by attacking cells that express particular proteins on their surface. Unfortunately, both diseased and healthy cells often express the same proteins, resulting in coll ...

· Scholar Rock is a biopharmaceutical company that discovers, develops, and delivers life-changing therapies for people with serious diseases that have high unmet need. As a global leader in the biology of the transforming growth factor beta (TGFβ) superfamily of cell proteins a ...

· Who is BlueRock? · BlueRock Therapeutics LP is a clinical stage cell therapy harnessing the power of cell therapy to create a pipeline of new medicines for people suffering from neurological and ophthalmic diseases. Two of our novel investigational cell therapies, bemdaneproce ...

Who is BlueRock? · BlueRock Therapeutics LP is a clinical stage cell therapy harnessing the power of cell therapy to create a pipeline of new medicines for people suffering from neurological and ophthalmic diseases. Two of our novel investigational cell therapies, bemdaneprocel ( ...

Who is BlueRock? · BlueRock Therapeutics LP is a clinical stage cell therapy harnessing the power of cell therapy to create a pipeline of new medicines for people suffering from neurological and ophthalmic diseases. Two of our novel investigational cell therapies, bemdaneprocel ...